|Articles|January 15, 2002
TNF monoclonal antibody acts fast to resolve panuveitis
Patients with Beh}et's disease can find rapid relief from vision-threateninginflammation
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Iolyx Therapeutics and Laboratoires Théa enter into agreement over ILYX-002 for the treatment of OSD
2
Avisi Technologies treats first patient in SAPPHIRE trial for glaucoma
3
FDA approves Amneal Pharmaceuticals' cyclosporine ophthalmic emulsion 0.05%
4
Eydenzelt, Celltrion’s biosimilar referencing Eylea, approved in Canada
5











































.png)


